We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection (RisVac02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00679497
Recruitment Status : Completed
First Posted : May 19, 2008
Last Update Posted : February 22, 2013
Information provided by (Responsible Party):
Juan A. Arnaiz, Hospital Clinic of Barcelona